Back to EPRX
CITADEL ADVISORS LLC EPRX Position History
Eupraxia Pharmaceuticals Inc. • Healthcare
Quarters held
8
Latest value
$644K
Q2 2026
Peak value
$2.7M
First seen
Q1 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2025 | $39K |
| Q2 2025 | $108K |
| Q1 2026 | $1.6M |
| Q1 2026 | $102K |
| Q2 2026 | $2.7M |
| Q2 2026 | $644K |
| Q2 2026 | $2.7M |
| Q2 2026 | $644K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $644K | 97.4K | — | — |
| Q2 2026 | $2.7M | 404.6K | — | — |
| Q2 2026 | $644K | 97.4K | — | — |
| Q2 2026 | $2.7M | 404.6K | — | — |
| Q1 2026 | $102K | 14.1K | — | — |
| Q1 2026 | $1.6M | 216.1K | — | — |
| Q2 2025 | $108K | 18.2K | — | — |
| Q1 2025 | $39K | 12.1K | — | — |
Other funds holding EPRX
$12.9M
$12.3M